Neogen Corporation (NASDAQ:NEOG) is a top healthcare stock facing operational challenges and a CEO departure in 2025. Despite weaker Q3 earnings, the company is divesting non-core operations to reduce debt and improve growth prospects, focusing on Food Safety and Animal Safety diagnostics for global markets.

In a strategic move, Neogen Corporation (NASDAQ:NEOG) collaborated with Biomatter in August 2025, showing a shift towards biotechnological innovation. Despite a sales decline, Q2 CY2025 results exceeded revenue expectations, demonstrating resilience in a tough market. Investors view the restructuring positively, anticipating a stronger rebound.

While Neogen Corporation (NASDAQ:NEOG) shows promise as an investment, some believe AI stocks offer greater potential with less risk. For those seeking an undervalued AI stock benefitting from Trump-era tariffs and onshoring trends, explore the report on the best short-term AI stock. Check out The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money for more insights.

Read more at Yahoo Finance: Neogen Corp (NEOG) Beats Expectations Amid Leadership Change and Restructuring Efforts